Assert-IQ vs FibriCheck
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your healthcare system requires a robust, long-term solution for continuous cardiac monitoring in patients with suspected or difficult-to-diagnose arrhythmias, where an implantable device offers superior data fidelity and extended monitoring periods. This system is ideal for comprehensive arrhythmia detection and proactive clinician alerts, enabling precise diagnosis and management over several years.
View Assert-IQ →Choose FibriCheck if…
Choose FibriCheck if you need a user-friendly, on-demand heart rhythm monitoring solution that leverages patient-owned smartphones for convenient and frequent checks. This tool is well-suited for patients who benefit from self-monitoring for conditions like Atrial Fibrillation, providing immediate results and allowing healthcare providers to oversee trends through a dedicated portal without the need for an invasive procedure.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | FibriCheck |
|---|---|---|
| Pricing | Unknown | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Subcutaneously implanted device with mobile app connectivity | Cloud-based (private cloud). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FibriCheckFibriCheck offers superior patient usability due to its non-invasive, smartphone-only approach, requiring no additional hardware or medical procedure for the patient. Assert-IQ, while offering long-term passive monitoring after insertion, still requires a minimally invasive procedure and a separate patient activator for symptom logging, making its initial and active patient interaction less straightforward than FibriCheck's app-based solution.
Clinical Value
Assert-IQAssert-IQ offers continuous, long-term monitoring for up to 6 years, which is crucial for detecting infrequent arrhythmias and provides a more comprehensive, high-fidelity data stream for diagnosis and management. While FibriCheck is highly accurate and clinically validated for intermittent monitoring, the continuous nature and extended duration of Assert-IQ's data collection provide a deeper and more robust clinical picture, especially for elusive cardiac events.
Pricing & Value
FibriCheckFibriCheck offers superior pricing transparency and flexibility with clear subscription models for both end-users and healthcare providers, including specific pricing for doctor-prescribed use. Its reimbursability under Medicare RPM codes also adds significant value for healthcare systems. Assert-IQ's enterprise-only pricing lacks public transparency, making direct value comparison difficult.
Enterprise Readiness
FibriCheckBoth tools demonstrate strong enterprise readiness, but FibriCheck boasts API-based integration with EHRs and RPM platforms, and has already integrated with over 100 healthcare systems, indicating proven scalability and interoperability in diverse clinical workflows. Assert-IQ, backed by Abbott, is designed for large health systems with hybrid deployment and remote programming, but FibriCheck's demonstrated widespread integration gives it a slight edge.
Innovation
FibriCheckFibriCheck demonstrates greater disruptive innovation by leveraging existing consumer smartphones to provide a medically certified, accessible, and scalable heart rhythm monitoring solution, effectively turning a common device into a diagnostic tool. While Assert-IQ offers significant advancements in implantable cardiac monitor longevity and AI-driven data reduction, FibriCheck's approach fundamentally redefines accessibility to cardiac screening and monitoring for a broader population.
Support & Docs
TieBoth tools offer comprehensive support and documentation tailored to their respective products and user bases. Assert-IQ provides extensive clinician and patient manuals critical for an implantable device system. FibriCheck offers a dedicated Help Center, a 'FibriCheck Academy,' and virtual training for its digital platform, ensuring robust user education and assistance.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | FibriCheck |
|---|---|---|
| Name | Assert-IQ | FibriCheck |
| Company | Abbott Medical | Qompium nv |
| Description Summary | Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone. |
| Patient Interface / Mobile App | Patient activator for symptom logging (mobile app: none) | Patient-facing mobile application |
| Key Monitoring Technology | Insertable Cardiac Monitor (ICM) with Bluetoothu00ae Low Energy data transmission | Smartphone camera-based PPG technology for heart rhythm measurement |
| Data Access for Clinicians | Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Data export: yes | Healthcare professional portal/dashboard for patient monitoring |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and FibriCheck.